Amgen Submits Biologics License Application To The FDA For Erenumab

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. DFTX
8. LLY
9. RGNX
10. LCO

Go back to Amgen Submits Biologics License Application To The FDA For Erenumab
Amgen Inc (NASDAQ: AMGN) Delayed: 344.43 +6.83 (2.02%)
Previous Close $337.60    52 Week High $176.85 
Open $337.65    52 Week Low $133.64 
Day High $344.98    P/E 51.87 
Day Low $337.60    EPS $6.64 
Volume 600,266